The Advisory Committee on Immunization Practices’ Interim Rec.for Additional Primary and Booster Doses of COVID-19 Vaccines — U.S. 2021

Mbaeyi, Sarah; Oliver, Sara E.; Collins, Jennifer P.; Godfrey, Monica; Goswami, Neela D.; Hadler, Stephen C.; Jones, Jefferson; Moline, Heidi; Moulia, Danielle; Reddy, Sujan; Schmit, Kristine; Wallace, Megan; Chamberland, Mary; Campos-Outcalt, Doug; Morgan, Rebecca L.; Bell, Beth P.; Brooks, Oliver; Kotton, Camille; Talbot, H. Keipp; Lee, Grace; Daley, Matthew F.; Dooling, Kathleen

doi:10.15585/MMWRmm7044e2

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

The Advisory Committee on Immunization Practices’ Interim Rec.for Additional Primary and Booster Doses of COVID-19 Vaccines — U.S. 2021

11 05 2021
By Mbaeyi, Sarah ; Oliver, Sara E. ; Collins, Jennifer P. ; ...
http://dx.doi.org/10.15585/MMWRmm7044e2
Source: MMWR Morb Mortal Wkly Rep. 70(44):1545-1552

[PDF-145.73 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

MMWR Morb Mortal Wkly Rep
Personal Author:

Mbaeyi, Sarah ; Oliver, Sara E. ; Collins, Jennifer P. ; Godfrey, Monica ; Goswami, Neela D. ; ... More +

Mbaeyi, Sarah ; Oliver, Sara E. ; Collins, Jennifer P. ; Godfrey, Monica ; Goswami, Neela D. ; Hadler, Stephen C. ; Jones, Jefferson ; Moline, Heidi ; Moulia, Danielle ; Reddy, Sujan ; Schmit, Kristine ; Wallace, Megan ; Chamberland, Mary ; Campos-Outcalt, Doug ; Morgan, Rebecca L. ; Bell, Beth P. ; Brooks, Oliver ; Kotton, Camille ; Talbot, H. Keipp ; Lee, Grace ; Daley, Matthew F. ; Dooling, Kathleen Less -
Corporate Authors:

U.S. Advisory Committee on Immunization Practices
Description:

Three COVID-19 vaccines are currently approved under a Biologics License Application (BLA) or authorized under an Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) and recommended for primary vaccination by the Advisory Committee on Immunization Practices (ACIP) in the U.S.: the 2-dose mRNA-based Pfizer-BioNTech/Comirnaty and Moderna Covid-19 Vaccines and the single-dose adenoVirus vector-based Janssen (Johnson & Johnson) COVID-19 vaccine (1,2) (Box 1). In August 2021, FDA amended the EUAs for the two mRNA COVID-19 vaccines to allow for an additional primary dose in certain immunocompromised recipients of an initial mRNA COVID-19 vaccination series (1). During September-October 2021, FDA amended the EUAs to allow for a COVID-19 vaccine booster dose following a primary mRNA COVID-19 vaccination series in certain recipients aged ≥18 years who are at increased risk for serious Complications of COVID-19 or exposure to SARS-CoV-2 (the Virus that causes COVID-19), as well as in recipients aged ≥18 years of Janssen COVID-19 vaccine (1) (Table). For the purposes of these recommendations, an additional primary (hereafter additional) dose refers to a dose of vaccine administered to persons who likely did not mount a protective immune response after initial vaccination. A booster dose refers to a dose of vaccine administered to enhance or restore protection by the primary vaccination, which might have waned over time. Health care professionals play a critical role in COVID-19 vaccination efforts, including for primary, additional, and booster vaccination, particularly to protect patients who are at increased risk for severe illness and death.
Subjects:

[+]

Adolescent Adult Adverse Drug Reaction Reporting Systems Advisory Committees Aged CoronaVirus Infections COVID-19 COVID-19 Vaccines Drug Approval Humans Immunization Middle Aged Practice Guidelines As Topic Young Adult
Source:

MMWR Morb Mortal Wkly Rep. 70(44):1545-1552
Pubmed ID:

34735422
Pubmed Central ID:

PMC8568093
Document Type:

Journal Article
Name as Subject:

Centers for Disease Control and Prevention (U.S.) ; U.S. Food and Drug Administration. ; Centers for Disease Control and Prevention (U.S.) ; U.S. Food and Drug Administration.

Centers for Disease Control and Prevention (U.S.) ; U.S. Food and Drug Administration. ; Centers for Disease Control and Prevention (U.S.) ; U.S. Food and Drug Administration. Less -
Place as Subject:

U.S.
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha256:7820af6529580fe2032623290afcc5502d971acf971601e7fed07c95796f9d3b
Download URL:

https://stacks.cdc.gov/view/cdc/111849/cdc_111849_DS1.pdf
File Type:

mm7044e2.nxml

xml

More +